Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

H ealth officials in the UK are launching an investigation into weight loss drugs after hundreds of consumers reported ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

CVS is set to drop Zepbound as a medicine, but will continue to carry other popular weight loss drugs instead.

The country’s Medicines and Healthcare products Regulatory Agency’s Yellow Card scheme, the UK’s official system for ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

Researchers say GLP-1 medicines might be able to help with migraines.

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

The two largest health insurers in Massachusetts are effectively telling the drug companies that they may seek a rapidly ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.